Riskpilot← Back to searchSign inGet full accessSECMA ApS
APSActiveCVR 29841985Møllerisvej 4Wholesale of pharmaceutical and medical goods · NACE 4646Est. 200622 employees
Revenue 2025
DKK 26M
-18% vs 2024
EBITDA margin
42.3%
-43% vs 2024
Equity ratio
25.6%
Financial strength
Net profit 2025
DKK 9,4M
-38% vs 2024
| Revenue | DKK 26M | -18% |
| EBITDA | DKK 11M | -43% |
| Net profit | DKK 9,4M | -38% |
| Total assets | DKK 49,3M | -20% |
| Equity | DKK 12,6M | -31% |
| Employees | 22 | — |
Legal name
SECMA ApS
CVR number
29841985
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
4. september 2006
Share capital
DKK 156.250
Employees
22 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-04-30
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsens formand eller den administrerende direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er salg og markedsføring af medicinsk udstyr.
Address
Møllerisvej 4
Phone
+4587101425
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.457 | 10.967 | 16.669 | 17.711 | 17.885 | 26.453 | 28.139 | 30.654 | 31.215 | 39.883 | 30.684 | 23.666 | 31.764 | 26.035 |
| Staff expenses | -4.602 | -5.590 | -6.314 | -7.219 | -7.766 | -8.984 | -7.650 | -8.595 | -8.369 | -10.214 | -10.746 | -10.389 | -12.576 | -15.022 |
| EBITDA | 4.855 | 5.377 | 10.355 | 10.492 | 10.119 | 17.470 | 20.489 | 22.024 | 22.846 | 25.543 | 19.938 | 13.277 | 19.188 | 11.013 |
| Depreciation & amort. | -219 | -180 | -189 | -280 | -337 | -395 | -292 | -292 | -372 | -384 | -421 | -468 | -400 | -533 |
| EBIT | 4.636 | 5.198 | 10.166 | 10.213 | 9.782 | 17.075 | 20.197 | 21.732 | 22.475 | 25.158 | 19.517 | 12.809 | 18.788 | 10.480 |
| Net financials | 713 | 759 | 342 | -1.299 | 14 | 222 | 285 | -464 | -54 | 908 | -228 | -1.445 | 526 | 1.536 |
| Profit before tax | 5.349 | 5.956 | 10.508 | 8.914 | 9.796 | 17.297 | 20.482 | 21.268 | 22.421 | 26.066 | 19.289 | 11.363 | 19.313 | 12.016 |
| Tax | -0 | 1.323 | 2.520 | 2.035 | 2.172 | 3.774 | 4.452 | 4.676 | 4.932 | 5.779 | 4.237 | 2.688 | 4.013 | 2.583 |
| Net profit | 4.161 | 4.633 | 7.988 | 6.879 | 7.624 | 13.523 | 16.031 | 16.591 | 17.489 | 20.287 | 15.052 | 8.675 | 15.301 | 9.433 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 14.795 | 13.169 | 28.897 | 29.930 | 28.507 | 26.980 | 35.789 | 40.734 | 53.435 | 38.032 | 37.191 | 42.734 | 61.558 | 49.327 |
| Equity | 6.090 | 7.223 | 11.211 | 10.190 | 10.814 | 16.737 | 19.267 | 19.858 | 20.848 | 23.634 | 18.687 | 11.504 | 18.205 | 12.637 |
| Long-term debt | 0 | 1.227 | 2.250 | 0 | 0 | 0 | 0 | 0 | 466 | 676 | 0 | 0 | 0 | 0 |
| Short-term debt | 8.705 | 4.704 | 15.322 | 19.636 | 17.584 | 10.189 | 16.459 | 20.854 | 32.077 | 13.678 | 18.467 | 31.161 | 43.257 | 36.578 |
| Total debt | 8.705 | 5.931 | 17.571 | 19.636 | 17.584 | 10.189 | 16.459 | 20.854 | 32.543 | 14.354 | 18.467 | 31.161 | 43.257 | 36.578 |
EBITDA margin
42.3%
This company
15.8%
Market median
+168% vs market
20122025
Equity ratio
25.6%
This company
38.2%
Market median
-33% vs market
20122025
Return on equity
74.6%
This company
18.4%
Market median
+305% vs market
20122025
Net profit margin
36.2%
This company
8.1%
Market median
+347% vs market
20122025
Asset turnover
0.53×
This company
1.12×
Market median
-53% vs market
20122025
Debt / equity
2.90×
This company
0.62×
Market median
-368% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via CVR / Virk · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via CVR / Virk · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via CVR / Virk · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via CVR / Virk · Period 2016-05-01 – 2017-04-30
- Annual report 2016Filed via CVR / Virk · Period 2015-05-01 – 2016-04-30
- Annual report 2015Filed via CVR / Virk · Period 2014-05-01 – 2015-04-30
- Annual report 2014Filed via CVR / Virk · Period 2013-05-01 – 2014-04-30
- Annual report 2013Filed via CVR / Virk · Period 2012-05-01 – 2013-04-30
- Annual report 2012Filed via CVR / Virk · Period 2011-05-01 – 2012-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HR Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2006 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2006 | — | — | |
| Chairman | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
GLID HOLDING ApS | Company | 50.0% | 50.0% | 2010 |
HENRIK RUBY HOLDING ApS | Company | 33.3% | 33.3% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
GLID HOLDING ApS
SECMA ApS Board members of SECMA ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Ruby | Chief Executive Officer | 0 companies |
| Heinz Kvottrup Lorentzen | Board of Directors | 0 companies |
| Lars Dahl Allerup | Board of Directors | 0 companies |
| Michael Maigaard Nielsen | Board of Directors | 0 companies |
| Jesper Lolk-Nielsen | Chairman | 0 companies |